Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: vestor who wrote (1256)	5/23/1999 9:16:00 PM
From: Thure Meyer	Respond to of 1837

Vestor, I also looked around for coverage. Haven't found any. Its hard to downgrade from buy to hold if no initial coverage exists. Maybe someone dug up a very old post and read it wrong. In any case this story doesn't need Warburg Dillon Reid. It only needs Cenestin sales. All this fishing around for other opinions is a waste of time. If there were a real news item associated with this, it would have hit the wires. The horse piss smells for itself. Thure